.png?width=647&height=188&name=Biomarkers%20%26%20Precision%20Medicine%202025%20Logo%20(White).png "Biomarkers & Precision Medicine 2025 Logo (White)")
.png?width=444&height=134&name=Precision%20Medicine%20Awards%202025%20Logo%20(Light).png "Precision Medicine Awards 2025 Logo (Light)")
Meet Our Expert Speakers
Biomarkers & Precision Medicine 2025 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.
Elena Miranda
Director, Non Clinical Histology,
GSK
Espen Walker
Global Head Medical Diagnostics,
AstraZeneca
Jeroen van der Laak
Professor of Computational Pathology,
Radboudumc
Marcus Otte
Senior Director, Head of Clinical Biomarker and Technologies,
Merck Healthcare KGaA
Maria Orr
Head of Precision Medicine and Biosamples, Early Oncology,
AstraZeneca
Matt Brown
Chief Scientific Officer,
Genomics England
Paul van Diest
Professor and Head, Department of Pathology,
University Medical Center Utrecht
Professor Sir Mark Caulfield
Vice Principal for Health,
Queen Mary’s Faculty of Medicine and Dentistry
Stephanie Craig
Lecturer in Precision Medicine,
Queen's University Belfast
Sushma Iyengar
Senior Director, Global Regulatory Affairs, Precision Medicine & Digital Health,
Takeda
Svetlana Mukhina
Director Global Regulatory Affairs, Global Regulatory Affairs CDx,
Merck Group
Virginia Savova
Senior Director,
AstraZeneca
Alain Van Gool
Professor Personalized Healthcare,
Radboud University Medical Center
Amonida Zadissa
Associate Director of Informatics,
UK Dementia Research Institute
Ana Hidalgo Sastre
Director, Translational Science,
AstraZeneca
Antonina Mitrofanova
Associate Professor and Associate Dean for Research,
Rutgers Health, SHP
Arman Rahman
Assistant Professor,
University College Dublin
Arthur Lewis
Director – Image Analysis & Platform - Pathology,
Astrazeneca
Azam Hamidinekoo
Senior Data Scientist, Clinical Pharmacology & Safety Sciences,
AstraZeneca
Belinda Nedjai
Reader/ Associate Professor in cancer biomarker and Epigenetic,
Queen Mary University Of London
Bernd Wollscheid
Professor & Group Leader, Head of Proteomics Platform,
ETH Zurich
Chris Bray
Head Global Regulatory Affairs, Precision Medicine & Companion Diagnostics,
Merck Healthcare KGaA
Daniel Strasser
Director, Therapeutic Area Biomarker Lead / Biomarker Strategy Immunology,
Novartis
David Clark
Consultant Haematopathologist,
Nottingham University Hospitals NHS Trust
David Snead
Founding Director, PathLAKE & Professor of Pathology Practice at University of Warwick,
PathLAKE
Debayan Mukherjee
Principal Scientist,
GSK
Emanuela Oldoni
Scientific Programme Manager- Biomarkers,
EATRIS
Emmanuel Valentin
Vice President, Translational Medicine,
Imcheck Therapeutics
Fan Liu
Head of the Proteomics Research Platform,
FMP Berlin
Francesca Trapani
Scientific Director/ Group Leader,
Boehringer Ingelheim
Gayle Marshall
Head of Biomarkers,
Catapult Medicines Discovery
Giovanna Lalli
Director, Strategy & Operations,
LifeArc
Harpreet Saini
Senior Director Bioinformatics,
Astex Pharmaceuticals
Helen Graves
Principal Scientist,
Alchemab Therapeutics
Henoch Hong
Associate Director,
Merck & Cie KmG
Huw Bannister
Senior Director, Global Commercial Digital and Computational Pathology,
AstraZeneca
Inês Sequeira
Group Leader,
Queen Mary University of London
Irene Del Molino del Barrio
Principal Scientist,
GSK
Jan-Philipp Mallm
Lab head,
DKFZ
Jean-Baptiste Lugagne
Group Leader,
Centre for Medicines Discovery
Jean-Christophe Olivo-Marin
Professor & Head of the Quantitative Image Analysis Unit,
Institute Pasteur
Jens Kieckbusch
Director, External Innovation Precision Medicine,
GlaxoSmithKline
Jim Eyles
Director, Clinical Immuno-Oncology Discovery Group,
AstraZeneca
Jimmy Bell
Professor,
University of Westminster
Jo Taylor
Founder,
METUPUK
Joanna Janus
Research Programme Manager,
Cancer Research UK
Joao Pinto
Surgical Pathologist,
University of Porto
Johan Luthman
Executive Vice President & Head of Research & Development,
Lundbeck
Karl Smith-Byrne
Senior Molecular Epidemiologist,
Centre for Medicines Discovery
Katherine Freeman
Senior Portfolio Manager, Digital Health,
UK Research Councils
Kazumasa Kanemaru
Postdoctoral Researcher,
University of Cambridge
Kiri Granger
Chief Scientific Officer,
Monument Therapeutics
Laurent Audoly
CEO, Co-Founder,
PriveBio
Lindsay Darling
Director, Companion Diagnostics Portfolio Management & Operations,
Regeneron
Liz Harrington
Executive Director, Translational Medicine Global Head of Targeted Therapy Franchise (TDE),
AstraZeneca
Mani Mudaliar
Director, Quantitative Biomarkers,
Recursion
Manuela Cerina
Scientific Director of Neurodegeneration,
LifeArc
Maria Laura Garcia Bermejo
Scientific Director,
Ramon y Cajal Health Research Institute (IRYCIS)
Markus Schulze
Senior Scientist,
Merck & Cie KmG
Martin Isabelle
Associate Director, Tumour Profiling and Mechanistic Biology, Translational Sciences,
Adaptimmune
Matthew Humphries
Director of Research Operations,
NHS
Michael Zaiac
Head of Medical Affairs Oncology Region Europe,
Daiichi Sankyo
Michael Cannarile
Head of Oncology Biomarkers,
Roche
Mike Messenger
Head of Regulatory Strategy,
BIVDA
Miro Venturi
Operating Partner,
ARCHIMED
Nathalie Banner
Director of Ethics,
Genomics England
Neil Humphryes-Kirilov
Associate Director of Human Genomics,
C4X Discovery
.jpg?length=600&name=3bb203aa-c4df-434c-9eb3-a974fad3766c-2-11764368speaker_photo-1516569446425-(2).jpg)
Nitin Jain
Director, Franchise Project Management,
AstraZeneca
Olga Nissan
Chief Executive Officer,
Protica Bio
Peter Groenen
Head of Translational Science,
Cerebrum DAO
Prakash Ramachandran
Professor of Experimental Hepatology,
University of Edinburgh
Raffaele A Calogero
Professor,
University of Torino
Rahul Deb
Consultant Pathologist, Clinical Lead for DP Implementation,
University Hospitals of Derby and Burton NHS Foundation
Richard Festenstein
Clinical Professor of Molecular Medicine,
Imperial College London
Roya Esat Dabestani
Precision Medicine Lead,
Innovate UK Business Connect
Sonali Natu
Clinical Lead Pathology & Consultant Cellular Pathologist,
Tees Valley Pathology; North Tees and Hartlepool NHS Foundation Trust; South Tees Hospitals NHS Foundation Trust
Thomas Jensen
Chief Executive Officer,
Allarity Therapeutics
Thomas Hach
Global Program Clinical Head,
Novartis
Valerie Taly
Group Leader,
University of Paris Descartes
Victoria Goss
Head of Early Diagnosis and Translational Group,
University of Southampton
Vihanga Pahalawatta
Director - Regulatory Affairs Companion Diagnostics,
AbbVie
Wanderson Dos Santos Trindade
Director Global Regulatory Affairs - Companion Diagnostics,
Daiichi-Sankyo
Wolfgang Breitwieser
Head of Molecular Biology,
Cancer Research -UK Manchester Institute
Meet Our Esteemed Sponsors
Platinum Sponsors
10x Genomics
Platinum Sponsor
10x Genomics was founded on the vision that this century will bring advances in biomedicine and transform the way we understand and treat disease. We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you unravel highly intricate biological systems, while bringing into focus the details that matter most.
Bruker Spatial Biology
Platinum Sponsor
Bruker Spatial Biology, a division of Bruker Corporation, provides advanced spatial molecular biology solutions, including instruments, assays, software, and services to support life sciences research. By integrating technologies from NanoString and Canopy Biosciences, Bruker offers an extensive portfolio designed to meet the diverse needs of global researchers exploring spatial biology. The CosMx® Spatial Molecular Imager (SMI) enables high-plex detection and analysis of over 6,000 RNAs with single-cell resolution and precise cell segmentation, supported by the cloud-based AtoMx™ Spatial Informatics Platform. The GeoMx® Digital Spatial Profiler is a leading platform for whole-tissue exploration, providing whole transcriptomics and high-plex proteomic readouts. The CellScape™ Precise Spatial Proteomics platform allows for high-plex protein expression analysis at single-cell resolution, using versatile, open-sourced reagents. The nCounter® Analysis System enables rapid quantification of profiling of gene and miRNA expression with high sensitivity. Together, Bruker Spatial Biology’s solutions are supported by a strong team of scientists, sales, and service associates, along with Canopy Multiomic Services for biopharmaceutical research, assay development, and clinical sample testing. For more information, visit www.BrukerSpatialBiology.com.
Gold Sponsors
ariadne.ai
Gold Sponsor
ariadne.ai ag is your partner for biomedical image analysis. Our cloud-based, worry-free SPATIAL platform enables the analysis of multiplexed spatial proteomics, transcriptomics and multi-omics data, including precise stitching, registration, segmentation and statistical analyses of cellular neighborhoods. SPATIAL works with any data type, whether you have fluorescence or histopathological staining, 2d or 3d data, or complex cell types such as neurons. Our experienced team of annotators and software engineers will design and implement custom solutions to any image analysis challenge, no matter the tissue, device or assay.
Cell Signaling Technology
Gold Sponsor
CST® is a privately-owned, global company headquartered in Danvers, Mass., USA. Founded in 1999 and still led by research scientists. We are actively engaged in the development of products and technologies that facilitate signaling analysis and mechanistic cell biology and cancer research.
Miltenyi Biotec, Ltd.
Gold Sponsor
For over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell analysis needs. Our solutions are designed to support everything from basic research to translational research and clinical application for immunology, stem cell biology, neuroscience, and cancer.
Quantum-Si
Gold Sponsor
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® Pro benchtop instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Detecting single amino acids through binding kinetics, the innovative Platinum® Pro benchtop sequencer is highly sensitive to protein variants, enabling deep interrogation of proteins to deliver breakthrough insights.
Singular Genomics
Gold Sponsor
Our recently launched G4X Spatial Sequencer, which is an upgrade to the G4 Sequencing Platform, is designed to offer high throughput in situ direct sequencing of RNA (Direct-Seq™), targeted transcriptomics, and proteomics profiling from formalin-fixed, paraffin-embedded (FFPE) tissues
Vizgen
Gold Sponsor
Vizgen is at the forefront of spatial biology and multi-omics innovation. Through its pioneering MERFISH technology and MERSCOPE® Platform for in situ single-cell spatial genomics and its high-fidelity InSituPlex® protein assays and AI-driven STARVUE™ spatial image analysis technology, Vizgen delivers unmatched tools that enable researchers to uncover deep insights into human biology and achieve breakthroughs in understanding mechanisms of complex diseases. Vizgen’s technology delivers high-confidence, quantitative data with exceptional accuracy, robustness, sensitivity and deep insights that power foundational and clinical research. Vizgen is headquartered in Cambridge, Massachusetts, and can be found online at www.vizgen.com and www.ultivue.com. Connect on social media Twitter, LinkedIn and Facebook.
Silver Sponsors
ACD, Bio-Techne
Silver Sponsor
ACD - a Bio-Techne brand, is a pioneer and leader in the advancement of spatial genomics and clinical applications by unlocking the power of RNA and developing cell- and tissue-based research and diagnostic tests for personalized medicine. Based in Silicon Valley, ACD’s proprietary RNAscope™ technology, the first multiplex fluorescent and chromogenic in situ hybridization platform, enables detection and quantification of single RNA molecules in situ. Our portfolio includes, RNAscope, BaseScope™, miRNAscope™ and HiPlex™ v2. With over 50,000 probes and our Professional Assay Services, we enable rapid assessment of unique targets. Since launch in 2011, the technology boasts 10,000+ citations, with new peer reviewed publications daily. Based on proprietary technology, ACD’s RNAscope Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform enables detection and quantification of RNA in situ at single molecule sensitivity.
Ardigen S.A.
Silver Sponsor
Ardigen is a leading AI Contract Research Organisation (CRO) dedicated to increasing the success rate of drug discovery. Recognized among the top 5% of AI in drug discovery companies worldwide, Ardigen integrates expertise in biology, bioinformatics, machine learning, and software engineering to deliver advanced computational solutions exclusively tailored for the biotechnology and pharmaceutical sectors. Over the past 10 years, we have earned the trust of over 120 clients, including 15 major pharmaceutical companies, by providing exceptional in silico research and data engineering services.
Complete Genomics
Silver Sponsor
Complete Genomics is a pioneering life sciences company offering innovative, comprehensive sequencing solutions, including sample/library preparation, lab automation, sequencing, and data analysis. Our sequencing portfolio features a full range of sequencers designed to meet low, medium, and high throughput needs, all powered by our proprietary DNBSEQ technology. To date, over 9,700 publications have utilized DNBSEQ technology across a broad spectrum of applications. As the exclusive distributor of STOmics products in North America, Complete Genomics provides access to Stereo-seq technology—the only spatial transcriptomics solution worldwide capable of exploring the entire transcriptome at true single-cell resolution. To learn more, visit https://www.completegenomics.com
GENEWIZ from Azenta Life Sciences
Silver Sponsor
As a global leader in R&D genomics services, GENEWIZ from Azenta Life Sciences, leads the way in providing superior data quality with unparalleled technical support to enable researchers around the world to advance their scientific discoveries faster than ever before. Our customers at top-tier pharmaceutical, biotechnology, and academic institutions, as well as cutting-edge start-ups, rely on our proprietary technologies for consistent, reliable, high-quality data, even on the most difficult projects. A full-service provider, we provides Sanger DNA sequencing, gene synthesis, molecular biology, high throughput/next generation sequencing, bioinformatics, and GLP regulatory services.
Hamilton
Silver Sponsor
Hamilton Company specializes in the development, manufacturing and customization of precision measurement devices, automated liquid handling workstations, and sample management systems. Hamilton's processes are optimized for quality and flexibility. Whether it's a custom needle with a quick delivery time frame, a special length pH sensor, or a comprehensive solution to fully automate your assay workflow, trust that Hamilton products will always meet your needs. Hamilton Company has been a leading global manufacturer for more than 60 years, with headquarters in Reno, Nevada;Franklin, Massachusetts;Timișoara, Romania;Bonaduz, Switzerland;and subsidiary offices throughout the world.
Lunaphore Technologies SA, a Bio-Techne company
Silver Sponsor
Lunaphore Technologies S.A. – a Bio-Techne brand, is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit https://lunaphore.com.
Navinci
Silver Sponsor
Navinci is a Swedish biotech company specializing in developing innovative solutions for studying protein interactions. With a focus and a strong legacy in developing in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.
NeoGenomics Laboratories
Silver Sponsor
NeoGenomics is a premier cancer diagnostics company, specializing in cancer genetics testing and information services. We offer one of the most comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing to help them diagnose and treat cancer. We partner with pharmaceutical clients from discovery to commercialization with broad oncology testing capabilities powered by in-house scientific expertise and dedicated project support teams. Our clients benefit from our state-of-the-art molecular technology, from whole exome sequencing, whole transcriptome sequencing, HLA typing, and the proprietary MultiOmyx™ high-order multiplexing methodology.
Olink
Silver Sponsor
Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways. Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base.
Parse Biosciences
Silver Sponsor
Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research. At the core of our company is our pioneering approach for single cell sequencing. Single cell sequencing has already enabled groundbreaking discoveries which have led to new understandings of cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
Sapient Bioanalytics
Silver Sponsor
Sapient is a leader in multi-omics discovery, providing bespoke services for proteomics, metabolomics, lipidomics data generation and delivering insights that enable biopharma sponsors to go beyond the genome to accelerate precision drug development. Utilizing cutting-edge, high throughput mass spectrometry, we make nontargeted and targeted measurements to capture thousands of dynamic biomarkers – including proteins, metabolites, and lipids – per sample, across thousands of samples at a time. We pair this with advanced biocomputational frameworks enabling comprehensive biomarker-phenotype mapping and integrative analyses with other omics and real-world data. Aided by our proprietary Human Biology Database — comprising data from tens of thousands of samples in which we can mine for and validate biomarkers and targets — we can support rapid drug target identification, biomarker discovery and validation, and translational insights across all stages of drug development, including clinical trials.
Scale Biosciences
Silver Sponsor
Scale Biosciences is at the forefront of a new era in single cell research, providing scientists with the tools they need to push the boundaries of biological discovery. Our innovative platforms combine accessibility, flexibility, and scalability, allowing researchers to design experiments that fit their unique scientific objectives without compromising on quality or results. By enabling the analysis of up to millions of cells and the multiplexing of hundreds of samples, Scale Bio empowers scientists to generate rich, comprehensive datasets that can unlock new insights into complex biological systems. We are dedicated to collaborating with the scientific community to drive innovation and accelerate breakthroughs in single cell-omics. Join Scale Bio on this transformative journey and help unleash the full potential of single cell research today.
Single Cell Discoveries
Silver Sponsor
Single Cell Discoveries is a Contract Research Organization (CRO) specializing in innovative single-cell sequencing technologies, multi-omic applications, and spatial transcriptomics. Single Cell Discoveries delivers high-impact insights to biopharmaceutical companies, healthcare systems, and academic research centers worldwide. Single Cell Discoveries' mission is to accelerate groundbreaking research by developing and providing state-of-the-art single-cell technologies as a service.
.jpg?length=600&name=a396bca6-7435-42de-8524-0ee4844b758e-2-5668375logo-standardbio-color-logo-blue-outline-blue-TM-(2).jpg){kind=logo}
Standard BioTools
Silver Sponsor
Standard BioTools™, previously known as Fluidigm®, is driven by a bold vision – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools provides an established portfolio of essential, standardized technologies that empower customers to scale and accelerate their life sciences research. From interrogating cell function and cancer-immune cell interactions to confidently determining new biomarkers or integrity of samples, Standard BioTools promotes the development of breakthrough medicines faster and better through the delivery of consistent, reliable and repeatable results.
Bronze Sponsors
Aspect Analytics
Bronze Sponsor
Aspect Analytics develops enterprise software to analyze and integrate spatial omics data. Spatial technologies are steadily maturing into a key enabler in drug development, biomarker discovery, and life science research. With spatial omics datasets commonly generating tens to hundreds of gigabytes of complex data in a single experiment, data analysis is becoming a critical bottleneck in the adoption of this emerging technology. Aspect Analytics bridges the gap between algorithmic development in bioinformatics research and enterprise-grade software platforms to support key spatial omics-based applications. Our software can (i) extract maximal knowledge from spatial data, including co-registration with different modalities, (ii) scale up for high-throughput applications and (iii) provide integrated data management, traceability and more. Aspect Analytics enables breakthrough research and facilitates cross-disciplinary teamwork by bringing spatial multi-omics data into a single view, collaborative platform.
Atrandi Biosciences
Bronze Sponsor
Atrandi Biosciences is a pioneering life sciences tool company transforming single-cell analysis with Semi-Permeable Capsule (SPC) technology. SPCs redefine how single-cell research is done, enabling multi-step, high-throughput workflows while maintaining true single-cell resolution. Unlike conventional methods, SPCs allow researchers to perform multiomic assays seamlessly, unlocking deeper insights into biology. Founded by leading scientists and driven by a mission to simplify research and advance discovery, Atrandi is shaping the future of single-cell analysis and empowering scientists worldwide.
Beckman Coulter
Bronze Sponsor
We are a life sciences company that provides an extensive portfolio of solutions for workflow innovation, lab automation of routine tasks/complex methods, and software solutions to advance your research. Our lab automation solutions and genomic reagents portfolio facilitate seamless processes for DNA/RNA clean-up, size selection, extraction, and sample preparation for NGS, RNA-seq, and single-cell transcriptomics. By integrating our advanced solutions into your lab, you can achieve high-quality, reproducible data, empowering your AI and machine learning models.
Becton Dickinson Biosciences
Bronze Sponsor
BD is a leading medical technology company that benefits countless lives worldwide. We advance health by improving the ways that discovery, diagnostics and delivery of care are conducted. With 45,000 employees at work in more than 50 countries, we work in close collaboration with customers and partners to develop innovative products and solutions that enhance outcomes, better manage healthcare delivery costs, increase efficiencies, improve healthcare safety, and expand access to health. Because we’ve been doing this for over 100 years, our portfolio, leadership and partnerships make a difference for global healthcare. For more information, please visit: www.bdbiosciences.com
CS Genetics
Bronze Sponsor
CS Genetics delivers simplicity in a world of complex, time-consuming and expensive single cell genomics workflows. Our nimble, experienced team understands that tomorrow’s discoveries require technology that is simple to adopt and easy to use with near-limitless scalability. Our transformative new technology for single cell genomics replaces complex hardware and manual time-consuming workflows with a simple, instrument-free, solution-based, Kinetic Confinement assay that plugs seamlessly into any molecular biology laboratory. This simplicity also enables an affordable price point so researchers will no longer have to limit the scale of their studies.
.png?length=600&name=23c79081-69ce-4042-a188-0a0e10023652-2-5668375logo-Hawk-(RGB-Full-Colour).png)
Hawk Biosystems
Bronze Sponsor
HAWK Biosystems is an innovative biotechnology company based in Bilbao, Spain, and a spin-off from prestigious institutions such as Cancer Research UK (CRUK) and the Francis Crick Institute in London. Founded in 2018 by an exceptional team of scientists and business leaders, HAWK has rapidly positioned itself at the forefront of spatial biology, providing ground-breaking solutions for the analysis of protein functions in tissue. At HAWK Biosystems, our mission is to develop advanced diagnostic systems that accelerate the progress of personalized medicine, focusing on critical diseases such as cancer. Our cutting-edge technology, QF-Pro®, is a revolutionary platform that enables precise, quantitative analysis of protein functions at a sub-pixel resolution. Unlike traditional techniques, QF-Pro® is capable of identifying protein-protein interactions and post-translational modifications within tissue samples at a resolution of less than 10 nanometers. This innovation provides clinicians and researchers with reproducible, robust, and unbiased data, which has demonstrated significant clinical value. For instance, QF-Pro® has been validated in a study to predict patient response to PD-1/PD-L1 inhibitors in lung cancer, demonstrating its potential to significantly improve treatment outcomes by potentially tripling response rates and doubling survival rates.
Leica Microsystems & Leica Biosystems
Bronze Sponsor
Leica Microsystems develops and manufactures microscopes and scientific instruments for the analysis of microstructures and nanostructures. Widely recognized for optical precision and innovative technology, the company is one of the market leaders in compound and stereo microscopy, digital microscopy, confocal laser scanning and super-resolution microscopy. Leica Biosystems (LeicaBiosystems.com) is a global leader in cancer diagnostics with the most comprehensive portfolio from biopsy to diagnosis. Our mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of our corporate culture. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence.
Levitasbio
Bronze Sponsor
LevitasBio is dedicated to advancing science and human health by providing researchers with new and powerful methods for sample preparation and characterization. The LeviCell platform is a first-in-class cell enrichment solution powered by a proprietary, label-free, and gentle Levitation Technology. Our unique solution generates high-quality samples while preserving the cells’ native state, enabling researchers across multiple scientific disciplines to uncover true biology. Accelerate Scientific Discovery With the Power of Levitation Technology
.png?length=600&name=3ebab810-7368-4d37-bc16-77d994699581-2-5668375logo-RareCyte_Logo_PMS7585-CoolGray11-(R).png){kind=logo}
RareCyte
Bronze Sponsor
RareCyte provides Precision Biology™ products and services for discovery, translational research and clinical diagnostics. The Orion™ spatial biology platform enables whole-slide highly multiplexed tissue analysis for multiple samples per day. Comprehensive liquid biopsy offerings enable CTC and other rare cell characterization and single cell retrieval for molecular analysis and CDx development.
.png?length=600&name=Zifo_Master%20Logo_Two%20colour_RGB%20(002).png)
Zifo Technologies
Bronze Sponsor
Zifo is a global specialist scientific and process informatics service provider working across research, development, manufacturing and clinical domains with expertise in over 90 partner technologies and platforms. We serve customers from Pharma/Biotech/CRO, Industrial chemicals and Food & Bev, to Consumer Goods and Oil and Gas. Our “Glocal” approach leverages remote delivery to ensure cost-effective delivery and solutions coupled with dedicated local support to ensure engagement, success and qualit
Network & Programme Sponsors
Aliri Bioanalysis
Network & Programme Sponsor
We provide a range of bioanalysis lab, spatial bioanalysis, and spatial biology solutions that will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of technical experts and seasoned scientists.
.svg){kind=logo}
BioLizard
Network & Programme Sponsor
At BioLizard, we “think data” and “speak biology”, partnering with our clients to transform lives. Our expert team combines deep biological knowledge with cutting-edge AI and bioinformatics to tackle complex data challenges in human and animal health. Through our AI-native Bio|Verse platform, we accelerate biomarker discovery and enable actionable insights for modern drug development. With a global presence, we deliver tailored solutions in data management, bioinformatics, and AI to drive your data-driven strategy to biotech, pharma and diagnostic companies. Let’s shape the future of life sciences together—connect with BioLizard today!
.png?length=600&name=77f962ea-48c4-4469-ac13-19f7332176c0-2-5668375logo-DLS-Logo-FullColor-noTag-(4).png){kind=logo}
Discovery Life Sciences
Network & Programme Sponsor
Discovery Life Sciences is a global leader in biospecimens and specialty lab services, enabling the discovery and development of groundbreaking therapeutics and diagnostics. With a robust portfolio of human biospecimens and cellular starting material, preclinical ADME-tox solutions, and cutting-edge specialty lab services, we provide our partners with the tools, data and expertise they need to succeed. From genomics and proteomics to cell biology and molecular pathology, our comprehensive service offerings support every phase of the scientific journey, from research through clinical trials. For more information, visit www.dls.com.
.png?length=600&name=708bd68b-02d3-4436-8882-e6181f86f6da-2-5668375logo-Horizontal-Logo-(White-Background).png){kind=logo}
Elucidate Biotechnologies
Network & Programme Sponsor
Elucidate Bio provides multi-modal spatial biology services, enabling same-tissue imaging of DNA, RNA, and protein with single-cell spatial resolution. Powered by technology licensed from Sizun Jiang at Harvard Medical School/BIDMC, we specialize in single-slide spatial proteomic, transcriptomic, and genomic data generation and analysis. With rigorous quality control, we deliver high-quality data, detailed analysis, and actionable insights to advance biomarker discovery, therapeutic development, and precision medicine. Contact Elucidate Bio to explore innovative spatial pipelines tailored to your program needs.
Psomagen
Network & Programme Sponsor
Psomagen, Inc., formerly Macrogen U.S.A., is a North American integrative omics solutions and contract laboratory services provider. The company makes cutting-edge technology and data analysis accessible to the academic, pharma, biotech and clinical markets. With both CLIA-certified and CAP-accredited facilities, its team delivers the highest-quality multiomics data using best-in-class DNA, RNA, and protein analysis systems. In conjunction with its bioinformatics capabilities, Psomagen offers a path to insights that is both simple and affordable. Learn more at psomagen.com.
Scailyte
Network & Programme Sponsor
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex molecular and cellular patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets. Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (scRNA-seq, CITE-seq, CyTOF, TCR-/BCR-seq, etc.) with clinical endpoints, such as disease progression, severity, treatment response and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. Our discoveries elucidate drug MoA and inform on the risk benefit ratio. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in various clinical projects in immunology and oncology.
.png?length=600&name=ccf7bc56-af8b-49fe-b50e-b8bdf467ba91-2-5668375logo-StellaromicsLogo-(7).png)
Stellaromics
Network & Programme Sponsor
Stellaromics is dedicated to pioneering breakthroughs in 3D spatial multi-omics. The company's mission is to empower researchers with cutting-edge tools that illuminate the complexities of biological systems, enabling groundbreaking discoveries that improve human health. The Stellaromics Pyxa platform enables researchers to visualize and analyze the spatial organization of cells and molecules within thick tissue samples at an unprecedented resolution. These breakthroughs, based on the company's STARmap and RIBOmap technologies, greatly expand upon applications of traditional 2D methods by offering a true 3D perspective, providing researchers with a deeper understanding of tissue organization, cellular interactions, and disease mechanisms.
Via Scientific
Network & Programme Sponsor
Via Scientific: AI-Powered Acceleration for Multi-Omics & Spatial Biology AI-Driven Bioinformatics Innovation: Via Foundry, Via Scientific’s AI-powered platform, accelerates multi-omics research by eliminating bioinformatics bottlenecks. It enables research teams to build custom analysis pipelines without coding, automating data processing so scientists can focus on discovery. Foundry acts as a “force multiplier” for biomedical research, dramatically reducing time to insights. Unified Multi-Omics & Spatial Insights: Designed for multi-omics and spatial biology, Via Foundry integrates genomics, transcriptomics, proteomics, and spatial data into a single platform. This fusion reveals deep biological insights missed by siloed analyses. With advanced visualization tools, Foundry handles large, complex datasets—accelerating discovery and development. Empowering Next-Gen Research Collaboration: Built by scientists for scientists, Via Foundry upholds rigorous standards while enabling seamless collaboration across teams and long-term studies. With flexible deployment in the cloud or on-premises, it is trusted across academia, biotech, pharma, and healthcare. Combining AI-driven technology with an intuitive design, Via Scientific empowers researchers to unlock insights faster, more reliably, and at scale.
Visiopharm
Network & Programme Sponsor
Visiopharm® is a leading provider of AI-driven precision pathology software for research and diagnostics. In research, it is a technology leader providing tools that help scientists, pathologists, and image analysis experts produce accurate data for all types of tissue-based research. In diagnostics, it is a leader within clinical applications, with no less than eight diagnostic algorithms cleared under IVDR for EU and UK customers. These applications provide diagnostic decision support and can be easily activated and integrated into existing lab workflows. Founded in 2002, Visiopharm is privately owned and operates internationally with over 750 customer accounts in more than 40 countries. The company's headquarters are located in Denmark's Medicon Valley, with legal entities in Sweden, the UK, Germany, the Netherlands, and the United States, and local representation in France and China.
Washington University
Network & Programme Sponsor
The McDonnell Genome Institute integrates cutting-edge ‘omics technologies and over 30 years of expertise to support your needs as your trusted partner. Explore our comprehensive solutions, including NGS, gene editing, stem cell biology, proteomics, and high-content imaging — custom-tailored to advance your research.
Start-Ups
Meet Our Esteemed Sponsors
Diamond Sponsor
Gold Sponsors
Discovery Life Sciences
Gold Sponsor
Discovery Life Sciences is a global leader in biospecimens and specialty lab services, enabling the discovery and development of groundbreaking therapeutics and diagnostics. With a robust portfolio of human biospecimens and cellular starting material, preclinical ADME-tox solutions, and cutting-edge specialty lab services, we provide our partners with the tools, data and expertise they need to succeed. From genomics and proteomics to cell biology and molecular pathology, our comprehensive service offerings support every phase of the scientific journey, from research through clinical trials. For more information, visit www.dls.com.
.jpg?length=600&name=82b4d7f4-9915-4502-9440-58a60a1b0f88-2-5668375logo-Q2_Solutions_logo.jpg-(2).jpg){kind=logo}
.jpg?length=600&name=bf44ff0a-0418-42b4-a2e0-4755d450c224-2-5668375logo-standardbio-color-logo-blue-outline-blue-TM-(2).jpg){kind=logo}
Standard BioTools
Gold Sponsor
Standard BioTools™, previously known as Fluidigm®, is driven by a bold vision – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools provides an established portfolio of essential, standardized technologies that empower customers to scale and accelerate their life sciences research. From interrogating cell function and cancer-immune cell interactions to confidently determining new biomarkers or integrity of samples, Standard BioTools promotes the development of breakthrough medicines faster and better through the delivery of consistent, reliable and repeatable results.
Silver Sponsors
.png?length=600&name=Foundation%20Medicine%20(2).png)
Bronze Sponsors
.jpg?length=600&name=d7563f0d-f009-49cd-8a2d-f682a079a3bb-2-5668375logo-ICON-Positive-logo-JPEG(nostrap).jpg){kind=icon}
.jpg?length=600&name=download%20(46).jpg)
Network & Programme Sponsors
QEII
Broad Sanctuary, London SW1P 3EE
Driving
Blue badge holders are permitted to park on the QEII Centre forecourt free of charge. Parking in this location is subject to availability so please call ahead on +44 20 7798 4000 to enquire.
Disabled passengers arriving by taxis or alternative vehicles may disembark on the forecourt.
Public Transport
Our nearest step-free tube station is Westminster, which is served by the Jubilee, District and Circle lines.
Information regarding accommodation for this event will be added soon
We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.
As we continue to move forward with hosting our events in-person in 2025, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.
Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.
Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.
If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Biomarkers & Precision Medicine 2025 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.
